Premium
Phase I/II study of weekly PM00104 (Zalypsis ® ) in patients with relapsed/refractory multiple myeloma
Author(s) -
Ocio Enrique M.,
Oriol Albert,
Bladé Joan,
Teruel Ana I.,
Martín Jesus,
Rubia Javier,
Gutiérrez Norma C.,
Rodríguez DíazPavón José,
Martínez González Sara,
Coronado Cinthya,
FernándezGarcía Eva M.,
Siguero Gómez Mariano,
FernándezTeruel Carlos,
San Miguel Jesus
Publication year - 2016
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13515
Subject(s) - lenalidomide , medicine , bortezomib , refractory (planetary science) , thalidomide , multiple myeloma , phases of clinical research , oncology , carfilzomib , gastroenterology , clinical trial , physics , astrobiology